Preoperative Short-Term Calorie Restriction for Prevention of Acute Kidney Injury After Cardiac Surgery: A Randomized, Controlled, Open-Label, Pilot Trial

被引:29
|
作者
Grundmann, Franziska [1 ,2 ]
Mueller, Roman-Ulrich [1 ,2 ,3 ]
Reppenhorst, Annika [1 ,2 ]
Huelswitt, Lennart [1 ,2 ]
Spaeth, Martin R. [1 ,2 ]
Kubacki, Torsten [1 ,2 ]
Scherner, Maximilian [4 ]
Faust, Michael [5 ]
Becker, Ingrid [6 ]
Wahlers, Thorsten [4 ]
Schermer, Bernhard [1 ,2 ,3 ]
Benzing, Thomas [1 ,2 ,3 ]
Burst, Volker [1 ,2 ]
机构
[1] Univ Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany
[2] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany
[3] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany
[4] Univ Cologne, Dept Cardiothorac Surg, Cologne, Germany
[5] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med, Cologne, Germany
[6] Univ Cologne, Inst Med Stat & Computat Biol, Cologne, Germany
来源
关键词
acute kidney injury; calorie restriction; cardiac surgery; dietary restriction; preconditioning; ISCHEMIA-REPERFUSION INJURY; DIETARY RESTRICTION; LIFE-SPAN; MORTALITY;
D O I
10.1161/JAHA.117.008181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Acute kidney injury is a frequent complication after cardiac surgery and is associated with adverse outcomes. Although short-term calorie restriction (CR) has proven protective in rodent models of acute kidney injury, similar effects have not yet been demonstrated in humans. Methods and Results-CR_KCH (Effect of a Preoperative Calorie Restriction on Renal Function After Cardiac Surgery) is a randomized controlled trial in patients scheduled for cardiac surgery. Patients were randomly assigned to receive either a formula diet containing 60% of the daily energy requirement (CR group) or adlibitum food (control group) for 7days before surgery. In total, 82 patients were enrolled between April 16, 2012, and February 5, 2015. There was no between-group difference in the primary end point of median serum creatinine increment after 24 hours (control group: 0.0 mg/dL [-0.1 - (+0.2) mg/dL]; CR group: 0.0 mg/dL [-0.2 - (+0.2) mg/dL]; P=0.39). CR prevented a rise in median creatinine at 48 hours (control group: +0.1 mg/dL [0.0 - 0.3 mg/dL]; CR group: -0.1 mg/dL [-0.2 - (+0.1) mg/dL]; P=0.03), with most pronounced effects observed in male patients and patients with a body mass index >25. This benefit persisted until discharge: Median creatinine decreased by 0.1 mg/dL (-0.2 - 0.0 mg/dL) in the CR group, whereas it increased by 0.1 mg/dL (0.0 - 0.3 mg/dL; P=0.0006) in the control group. Incidence of acute kidney injury was reduced by 5.8% (41.7% in the CR group compared with 47.5% in the control group). Safety-related events did not differ between groups. Conclusions-Despite disappointing results with respect to creatinine rise within the first 24 hours, the benefits observed at later time points and the subgroup analyses suggest the protective potential of short-term CR in patients at risk for acute kidney injury, warranting further investigation.
引用
收藏
页数:83
相关论文
共 50 条
  • [41] Chlorhexidine locking device for central line infection prevention in ICU patients: protocol for an open-label pilot and feasibility randomized controlled trial
    Nasim Zamir
    Makena Pook
    Ellen McDonald
    Alison E. Fox-Robichaud
    Pilot and Feasibility Studies, 6
  • [42] Urine alkalinisation to prevent contrast-induced acute kidney injury: the prospective, randomised, controlled, open-label TEATE trial
    Lombardi, Marco
    Molisana, Michela
    Genovesi, Eugenio
    De Innocentiis, Carlo
    Limbruno, Ugo
    Misuraca, Leonardo
    Moretti, Luciano
    Di Vito, Luca
    Renda, Giulia
    Zimarino, Marco
    Di Nicola, Marta
    De Caterina, Raffaele
    EUROINTERVENTION, 2022, 18 (07) : 562 - +
  • [43] Intravenous magnesium sulfate for prevention of vancomycin plus piperacillin-tazobactam induced acute kidney injury in critically ill patients: An open-label, placebo-controlled, randomized clinical trial
    Khalili, Hossein
    Rahmani, Hamid
    Mohammadi, Mostafa
    Salehi, Mohamadreza
    Mostafavi, Zahra
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 29 (02) : 341 - 351
  • [44] Comparison of short-term escitalopram vs lithium monotherapy for acute episode of bipolar depression: A randomized open label trial
    Kumatgi, Sumati
    Starlin, V. M.
    Reddy, M. S.
    Reddy, Swetha
    BIPOLAR DISORDERS, 2020, 22 : 91 - 92
  • [45] Reduction in acute kidney injury post cardiac surgery using balanced forced diuresis: a randomized, controlled trial
    Luckraz, Heyman
    Giri, Ramesh
    Wrigley, Benjamin
    Nagarajan, Kumaresan
    Senanayake, Eshan
    Sharman, Emma
    Beare, Lawrence
    Nevill, Alan
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 59 (03) : 562 - 569
  • [46] Effects of intraoperative dexmedetomidine on the incidence of acute kidney injury in pediatric cardiac surgery patients: A randomized controlled trial
    Kim, Eun-Hee
    Lee, Ji-Hyun
    Kim, Hee-Soo
    Jang, Young-Eun
    Ji, Sang-Hwan
    Kim, Woong-Han
    Kwak, Jae Gun
    Kim, Jin-Tae
    PEDIATRIC ANESTHESIA, 2020, 30 (10) : 1132 - 1138
  • [47] Intravenous magnesium sulfate for prevention of vancomycin plus piperacillin-tazobactam induced acute kidney injury in critically ill patients: An open-label, placebo-controlled, randomized clinical trial
    Hossein Khalili
    Hamid Rahmani
    Mostafa Mohammadi
    Mohamadreza Salehi
    Zahra Mostafavi
    DARU Journal of Pharmaceutical Sciences, 2021, 29 : 341 - 351
  • [48] The Potential Role of Albumin in Reducing Cardiac Surgery-Associated Acute Kidney Injury: A Randomized Controlled Trial
    Bagan, Jordi Miralles
    Quiles, Laura Parrilla
    Iglesias, Pilar Paniagua
    Roig, Antoni J. Betbese
    Tenas, Sergi Sabate
    Garcia, Sergio Perez
    Alvarez, Mercedes Garcia
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2025, 39 (02) : 453 - 460
  • [49] Perioperative sodium bicarbonate to prevent acute kidney injury after cardiac surgery: a multicenter double-blind randomized controlled trial
    A Haase-Fielitz
    M Haase
    M Plass
    P Murray
    M Bailey
    R Bellomo
    S Bagshaw
    Critical Care, 17 (Suppl 2):
  • [50] The Effects of Burst Steroid Therapy on Short-term Decongestion in Acute Heart Failure Patients With Pro-inflammatory Activation: A Post Hoc Analysis of the CORTAHF Randomized, Open-label, Pilot Trial
    Biegus, Jan
    Cotter, Gad
    Davison, Beth a.
    Freund, Yonathan
    Voors, Adriaan a.
    Edwards, Christopher
    Novosadova, Maria
    Takagi, Koji
    Hayrapetyan, Hamlet
    Mshetsyan, Andranik
    Mayranush, Drambyan
    Cohen-solal, Alain
    Maaten, Jozine m. ter
    Filippatos, Gerasimos
    Chioncel, Ovidiu
    Sadoune, Malha
    Pagnesi, Matteo
    Simon, Tabassome
    Metra, Marco
    Mann, Douglas l.
    Mebazaa, Alexandre
    Ponikowski, Piotr
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (02) : 354 - 366